Top Markets
Coin of the day
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
주식 순위 #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
주가
$0.117
마지막 동기화: 2025-04-04
시가총액
$2.45M
변동 (1일)
-13.59%
변동 (1년)
0.00%
국가
US
거래 Carmell Therapeutics Corporation (CTCX)

카테고리

Carmell Therapeutics Corporation (CTCX)의 EPS
June 2026 기준 EPS TTM: $-4.71
Carmell Therapeutics Corporation의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $-4.71입니다. 2023년 말에는 회사의 EPS가 $-0.74였으며, 이는 2022년의 EPS $-0.50와 증가입니다.
Carmell Therapeutics Corporation의 EPS 기록 (2021 ~ 2026)
매년 말의 EPS
연도 EPS 변화
2026 (TTM) $-4.71 842.00%
2024 $-0.50 -32.43%
2023 $-0.74 48.00%
2022 $-0.50 4,487.16%
2021 $-0.01 0.00%
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
$17.32 -467.73%
US
$27.74 -688.96%
NL
- -
CH
- -
KR
$13.70 -390.87%
BE